This implies that improvements in Hb levels from innovative treatments, in combination with transcranial Doppler ultrasonography screening and RBC transfusion therapy [47, 48], could reduce the incidence of stroke in pediatric patients with SCD. The gene discussed is GSTM1; the disease is stroke disorder.